TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
IONS

Ionis Pharmaceuticals Inc

Healthcare · Biotechnology

44.50$ +1.6% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Ionis Pharmaceuticals Inc (IONS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,995 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IONS
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,934 2,764 2,764 2,691 3,081 3,004 2,813 2,985 3,033 3,524 3,450 2,995
2,585 2,416 2,416 2,329 2,714 2,620 2,419 2,577 2,519 2,990 2,937 2,491
352 349 349 294 335 242 264 297 338 372 173 350
2,236 2,206 2,206 2,079 2,483 2,298 2,145 2,290 2,240 2,677 1,919 2,055
142 5.1 5.1 27 18 92 40 53 25 66 74 59
26 30 30 29 28 13 12 8.5 10 10 5.6 51
2,619 2,467 2,467 2,427 2,419 2,415 2,337 2,353 2,415 3,035 2,959 2,555
404 328 328 306 305 309 250 897 903 782 717 316
10.0 44 44 44 44 9.3 12 630 631 453 433 242
5.6 13 13 9.2 9.1 43 17 23 14 28 26 48
1,231 1,230 1,231 1,232 1,234 1,245 1,251 625 596 1,347 1,349 1,351
315 297 297 264 662 588 476 632 618 489 491 440
-1,787 -1,939 -1,939 -2,005 -2,145 -2,250 -2,397 -2,273 -2,402 -2,631 -2,724 -2,838
143 146 146 146 149 158 159 182 161 162 165 165

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?